2026-2034年全球胃滯留給藥系統市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，胃內給藥系統的市場規模將達到 376.3 億美元，而 2025 年為 208.3 億美元，預計 2026 年至 2034 年的複合年成長率將達到 6.79%。

全球胃滯留給藥系統市場正經歷強勁成長，這主要得益於市場對提高藥物吸收率和標靶給藥需求的不斷成長。這些系統旨在延長藥物在胃內的停留時間，從而提高生物利用度和療效。慢性病盛行率的上升以及對高效能給藥解決方案的需求正在推動市場擴張。此外，製藥技術的進步也為創新給藥系統的研發提供了支持。

成長要素包括患者對用藥依從性和藥物釋放控制的日益關注。胃滯留系統有助於減少給藥頻率並改善治療效果。加大對藥物研發的投入也促進了市場成長。此外，全球製藥業的擴張和對先進製劑日益成長的需求也支撐著市場發展。

未來，由於藥物遞送技術的不斷創新，胃滯留給藥系統的市場預計將顯著成長。隨著新配方和新材料的開發，其性能將進一步提升。新興市場有望因醫療保健覆蓋範圍的擴大而帶來巨大的成長機會。此外，個人化醫療的進步也將加速標靶給藥解決方案的普及應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球胃滯留藥物輸送系統市場：按類型分類

• 市場分析、洞察與預測
• 漂浮式藥物輸送系統
• 緩釋藥物輸送系統
• 生物黏附藥物遞送系統
• 高密度系統
• 其他

第5章：全球胃滯留給藥系統市場：依劑量分類

• 市場分析、洞察與預測
• 藥片
• 膠囊
• 凝膠
• 液體
• 其他

第6章：全球胃保留給藥系統市場：依分銷管道分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球胃滯留藥物輸送系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Catalent Inc
  • Lonza
  • Evonik Industries AG
  • Colorcon
  • Quotient Sciences
  • AptarGroup Inc
  • Aenova Holding GmbH
  • Evotec SE
  • Vectura Group Ltd
  • Ashland

The Gastroretentive Drug Delivery Systems Market size is expected to reach USD 37.63 Billion in 2034 from USD 20.83 Billion (2025) growing at a CAGR of 6.79% during 2026-2034.

The global gastroretentive drug delivery systems market is witnessing strong growth due to increasing demand for improved drug absorption and targeted delivery. These systems are designed to prolong the retention of drugs in the stomach, enhancing their bioavailability and effectiveness. The rising prevalence of chronic diseases and the need for efficient drug delivery solutions are driving market expansion. Additionally, advancements in pharmaceutical technologies are supporting the development of innovative delivery systems.

Key growth drivers include the growing focus on patient compliance and controlled drug release. Gastroretentive systems help reduce dosing frequency and improve therapeutic outcomes. The increasing investment in pharmaceutical research and development is also contributing to market growth. Furthermore, the expansion of the global pharmaceutical industry and the rising demand for advanced drug formulations are supporting market development.

In the future, the gastroretentive drug delivery systems market is expected to grow significantly with continuous innovation in drug delivery technologies. The development of novel formulations and materials will further enhance performance. Emerging markets are anticipated to provide substantial growth opportunities due to increasing healthcare access. Additionally, advancements in personalized medicine will drive the adoption of targeted drug delivery solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Floating Drug Delivery System
• Expandable Drug Delivery System
• Bioadhesive Drug Delivery System
• High Density Systems
• Others

By Dosage

• Tablets
• Capsule
• Gel
• Liquid
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Catalent Inc, Lonza, Evonik Industries AG, Colorcon, Quotient Sciences, AptarGroup Inc, Aenova Holding GmbH, Evotec SE, Vectura Group Ltd, Ashland
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Floating Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Expandable Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioadhesive Drug Delivery System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. High Density Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY DOSAGE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Dosage
• 5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Capsule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Dosage
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Dosage
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Dosage
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Dosage
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Dosage
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Catalent Inc
  • 9.2.2 Lonza
  • 9.2.3 Evonik Industries AG
  • 9.2.4 Colorcon
  • 9.2.5 Quotient Sciences
  • 9.2.6 AptarGroup Inc
  • 9.2.7 Aenova Holding GmbH
  • 9.2.8 Evotec SE
  • 9.2.9 Vectura Group Ltd
  • 9.2.10 Ashland